These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12100088)

  • 1. A quantification of the placebo response in migraine prophylaxis.
    van der Kuy PH; Lohman JJ
    Cephalalgia; 2002 May; 22(4):265-70. PubMed ID: 12100088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.
    Meissner K; Fässler M; Rücker G; Kleijnen J; Hróbjartsson A; Schneider A; Antes G; Linde K
    JAMA Intern Med; 2013 Nov; 173(21):1941-51. PubMed ID: 24126676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral pulsed electromagnetic fields may reduce the placebo effect in migraine patients that do not respond to the sham intervention in a randomized, placebo-controlled, double-blind, cross-over clinical trial.
    San-Juan D; Pon AA; Pohls FZ; Del Castillo-Calcáneo Jde D; Pérez-Neri I; Ríos C
    Complement Ther Med; 2012; 20(1-2):31-7. PubMed ID: 22305246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo response in the prophylaxis of migraine: a meta-analysis.
    Macedo A; Baños JE; Farré M
    Eur J Pain; 2008 Jan; 12(1):68-75. PubMed ID: 17451980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
    Evers S; Marziniak M; Frese A; Gralow I
    Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.
    Silberstein S; Goode-Sellers S; Twomey C; Saiers J; Ascher J
    Cephalalgia; 2013 Jan; 33(2):101-11. PubMed ID: 23165696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study.
    van der Kuy PH; Merkus FW; Lohman JJ; ter Berg JW; Hooymans PM
    Cephalalgia; 2002 Sep; 22(7):513-9. PubMed ID: 12230592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.